Kovitz Investment Group Partners, LLC Eledon Pharmaceuticals, Inc. Transaction History
Kovitz Investment Group Partners, LLC
- $23.6 Billion
- Q3 2025
A detailed history of Kovitz Investment Group Partners, LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 732,975 shares of ELDN stock, worth $1.29 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
732,975Holding current value
$1.29 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
89Shares Held
32.2MCall Options Held
0Put Options Held
360K-
Bvf Inc San Francisco, CA6.29MShares$11.1 Million0.88% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$6.28 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$5.75 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.07MShares$3.65 Million0.21% of portfolio
-
Zimmer Partners, LP New York, NY1.83MShares$3.21 Million0.13% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $24.2M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...